Benjamin Halladay

Insider Reports History

Entity
Individual
Location
Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Halladay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Financial Officer Common Stock 482K $464K $0.96 Apr 17, 2025 Direct
Esperion Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 213K $345K $1.62 Mar 14, 2025 Direct

Insider Reports Filed by Benjamin Halladay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Apr 17, 2025 1 -$8 4 Apr 21, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 18, 2025 1 -$5.24K 4 Mar 19, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2025 2 $0 4 Mar 17, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Feb 19, 2025 1 -$21 4 Feb 20, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Jan 17, 2025 1 -$20 4 Jan 21, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Dec 17, 2024 1 -$7.87K 4 Dec 18, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Dec 9, 2022 2 $0 4 Dec 12, 2022 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Nov 16, 2022 0 $0 3 Nov 16, 2022 Chief Financial Officer